Efficacy and Safety of Vandetanib in Progressive and Symptomatic Medullary Thyroid Cancer: Post Hoc Analysis From the ZETA Trial

PURPOSE: We conducted a post hoc analysis of the vandetanib phase III trial involving patients with advanced medullary thyroid cancer (MTC) to assess the efficacy and safety of vandetanib in patients with progressive and symptomatic MTC. The primary objective of the analysis was to determine progres...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Kreissl, Michael C., Bastholt, Lars, Elisei, Rossella, Haddad, Robert, Hauch, Ole, Jarząb, Barbara, Robinson, Bruce, Colzani, Raffaella, Foster, Meredith, Weiss, Richard, Schlumberger, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7430220/
https://ncbi.nlm.nih.gov/pubmed/32584630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.02790
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados